blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2402443

EP2402443 - Therapeutic uses of inhibitors of rtp801 [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  09.09.2016
Database last updated on 03.10.2024
Most recent event   Tooltip09.09.2016Application deemed to be withdrawnpublished on 12.10.2016  [2016/41]
Applicant(s)For all designated states
Quark Pharmaceuticals, Inc.
6501 Dumbarton Circle
Fremont, California 94555 / US
For all designated states
Silence Therapeutics AG
Robert-Rössle-Strasse 10
13125 Berlin / DE
[2012/01]
Inventor(s)01 / Feinstein, Elena
13/55 HaCarmel Street
76305 Rehovot / IL
02 / Skaliter, Rami
10/7 David Elazar Street
74027 Nes Ziona / IL
 [2012/05]
Representative(s)Sellin, Carole, et al
Ernest Gutmann - Yves Plasseraud S.A.S 88, Boulevard des Belges
69452 Lyon Cedex 06 / FR
[2012/01]
Application number, filing date11172942.218.01.2007
[2012/01]
Priority number, dateUS20060760586P20.01.2006         Original published format: US 760586 P
US20060796901P01.05.2006         Original published format: US 796901 P
US20060851000P10.10.2006         Original published format: US 851000 P
[2012/01]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2402443
Date:04.01.2012
Language:EN
[2012/01]
Type: A3 Search report 
No.:EP2402443
Date:07.10.2015
Language:EN
[2015/41]
Search report(s)(Supplementary) European search report - dispatched on:EP07.09.2015
ClassificationIPC:C12N15/113, A61K31/713, // A61P27/16, A61P27/02
[2012/01]
CPC:
C07K16/18 (EP,US); A61K31/7088 (KR); A61K31/70 (KR);
A61P11/00 (EP); A61P11/06 (EP); A61P11/08 (EP);
A61P13/12 (EP); A61P25/00 (EP); A61P27/00 (EP);
A61P27/02 (EP); A61P27/16 (EP); A61P35/00 (EP);
A61P9/00 (EP); C07K14/4747 (EP,US); C07K16/22 (EP,US);
C12N15/113 (EP,US); A61K2039/505 (EP,US); C12N2310/14 (EP,US);
C12N2310/321 (EP,US) (-)
C-Set:
C12N2310/321, C12N2310/3521 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2012/01]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
RSNot yet paid
TitleGerman:Therapeutische Verwendungen von RTP801-Hemmern[2012/01]
English:Therapeutic uses of inhibitors of rtp801[2012/01]
French:Utilisations thérapeutiques d'inhibiteurs de rtp801[2012/01]
Examination proceduredeletedCommunication of intention to grant the patent
08.04.2016Application deemed to be withdrawn, date of legal effect  [2016/41]
17.05.2016Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2016/41]
Parent application(s)   TooltipEP07718224.4  / EP1984003
Fees paidRenewal fee
25.10.2011Renewal fee patent year 03
25.10.2011Renewal fee patent year 04
25.10.2011Renewal fee patent year 05
25.01.2012Renewal fee patent year 06
28.01.2013Renewal fee patent year 07
30.01.2014Renewal fee patent year 08
23.01.2015Renewal fee patent year 09
27.01.2016Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[AD]WO2004015107  (ATUGEN AG [DE], et al) [AD] 1-19 * the whole document *;
 [A]WO2004035615  (ATUGEN AG [DE], et al) [A] 1-19 * example 10 *;
 [AP]WO2006023544  (QUARK BIOTECH INC [US]) [AP] 1-19 * page 134; table B; compound 67 ** page 137; table C; compound 131 *;
 [A]  - NUTTALL, A., "Sound-induced cochlear ischemia/hypoxia as a mechanism of hearing loss", NOISE & HEALTH, (1999), vol. 5, pages 17 - 31, XP002501638 [A] 1-19 * the whole document *
 [A]  - HOLLEY ET AL, "Keynote review: The auditory system, hearing loss and potential targets for drug development", DRUG DISCOVERY TODAY, (20051001), vol. 10, no. 19, ISSN 1359-6446, pages 1269 - 1282, XP005105967 [A] 1-19 * the whole document *

DOI:   http://dx.doi.org/10.1016/S1359-6446(05)03595-6
 [A]  - SCHWARZER ROLF ET AL, "REDD1 integrates hypoxia-mediated survival signaling downstream of phosphatidylinositol 3-kinase", ONCOGENE, (20050210), vol. 24, no. 7, ISSN 0950-9232, pages 1138 - 1149, XP002353260 [A] 1-19 * the whole document *

DOI:   http://dx.doi.org/10.1038/sj.onc.1208236
 [A]  - BRAFMAN, A. ET AL., "Inhibition of oxygen-induced retinopathy in RTP801-deficient mice.", INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, (200410), vol. 45, no. 10, ISSN 0146-0404, pages 3796 - 3805, XP002501841 [A] 1-19 * the whole document *

DOI:   http://dx.doi.org/10.1167/IOVS.04-0052
by applicantUS4439196
 US4444887
 US4447233
 US4447224
 US4475196
 US4486194
 US4487603
 EP0239400
 US4716111
 US4925678
 US4959217
 WO9109967
 WO9110741
 US5167616
 US5169383
 EP0519596
 US5218088
 US5225539
 US5225347
 US5225182
 WO9323569
 EP0592106
 US5530101
 US5565332
 WO9634096
 WO9633735
 US5580859
 US5585089
 US5589466
 US5593972
 WO9816654
 WO9824893
 WO9846645
 WO9850433
 WO9909046
 US5898031
 EP0586520
 US6107094
 US6121426
 WO0105998
 WO0112659
 EP0618925
 WO0170979
 WO0177289
 WO0231111
 WO0244321
 WO0246465
 US6423493
 US2002119463
 US6455674
 WO02101075
 WO03010205
 US6555667
 US2003108871
 WO03070918
 US2003165864
 JP2003259877
 WO03101283
 US6673549
 US2004019001
 WO2004015107
 EP1394274
 WO2004018999
 US2004063654
 US6740738
    - PETTY TL., "Definition, epidemiology, course, and prognosis of COPD", CLIN. CORNERSTONE, (2003), pages 5 - 10
    - TUDER RM, "Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor blocade", AM J RESPIR CELL MOL BIOL, (2003), vol. 29, doi:doi:10.1165/rcmb.2002-0228OC, pages 88 - 97, XP009144404

DOI:   http://dx.doi.org/10.1165/rcmb.2002-0228OC
    - ERIKSSON, S., "Pulmonary Emphysema and Alphal-Antitrypsin Deficiency", ACTA MED SCAND, (1964), vol. 175, pages 197 - 205
    - JOOS, L., PARE, P.D., SANDFORD, A.J., "Genetic risk factors of chronic obstructive pulmonary disease", SWISS MED WKLY, (2002), vol. 132, pages 27 - 37
    - HAUTAMAKI ET AL., "Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice", SCIENCE, vol. 277, doi:doi:10.1126/science.277.5334.2002, pages 2002 - 2004, XP002258397

DOI:   http://dx.doi.org/10.1126/science.277.5334.2002
    - ZHENG, T. ET AL., "Inducible targeting ofIL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema", J CLIN INVEST, (2000), vol. 106, pages 1081 - 1093
    - RANGASAMI T ET AL., "Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-iduced emphysema in mice", JOURNAL OF CLININCAL INVESTIGATION
    - TUDER RM ET AL., "Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor blocade", AM JRESPIR CELL MOL BIOL, (2003), vol. 29, doi:doi:10.1165/rcmb.2002-0228OC, pages 88 - 97, XP009144404

DOI:   http://dx.doi.org/10.1165/rcmb.2002-0228OC
    - YOKOHORI N, AOSHIBA K, NAGAI A, "Increased levels of cell death and proliferation in alveolar wall cells in patients with pulmonary emphysema", CHEST., (200402), vol. 125, no. 2, pages 626 - 32
    - AOSHIBA K, YOKOHORI N, NAGAI A., "Alveolar wall apoptosis causes lung destruction and emphysematous changes", AM JRESPIR CELL MOL BIOL., (200305), vol. 28, no. 5, pages 555 - 62
    - HULEA SA ET AL., "Cigarette smoking causes biochemical changes in blood that are suggestive of oxidative stress: a case-control study", J ENVIRON PATHOL TOXICOL ONCOL., (1995), vol. 14, no. 3-4, pages 173 - 80
    - RAHMAN I, MACNEE W., "Lung glutathione and oxidative stress: implications in cigarette smoke-induced airway disease", AM J PHYSIOL., (199912), vol. 277, pages L1067 - 88
    - MACNEE W., "Oxidants/antioxidants and COPD", CHEST., (200005), vol. 117, no. 5, doi:doi:10.1378/chest.117.5_suppl_1.303S-a, pages 303S - 17S, XP003015003

DOI:   http://dx.doi.org/10.1378/chest.117.5_suppl_1.303S-a
    - MARWICK JA, KIRKHAM P, GILMOUR PS, DONALDSON K, MACNEE W, RAHMAN I., "Cigarette smoke-induced oxidative stress and TGF-betal increase p21waf1/cip1 expression in alveolar epithelial cells", ANN N YACAD SCI., (200211), vol. 973, pages 278 - 83
    - AOSHIBA K, KOINUMA M, YOKOHORI N, NAGAI A., "Immunohistochemical evaluation of oxidative stress in murine lungs after cigarette smoke exposure", INHAL TOXICOL., (200309), vol. 15, no. 10, pages 1029 - 38
    - DEKHUIJZEN PN., "Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease", EUR RESPIR J., (200404), vol. 23, no. 4, pages 629 - 36
    - TUDER RM, ZHEN L, CHO CY, TARASEVICIENE-STEWART L, KASAHARA Y, SALVEMINI D, VOELKEL NF, FLORES SC., "Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor blocade", AM JRESPIR CELL MOL BIOL, (2003), vol. 29, doi:doi:10.1165/rcmb.2002-0228OC, pages 88 - 97, XP009144404

DOI:   http://dx.doi.org/10.1165/rcmb.2002-0228OC
    - INHAL TOXICOL., (200309), vol. 15, no. 10, pages 1029 - 38
    - TAKAHASHI A, MASUDA A, SUN M, CENTONZE VE, HERMAN B., "Oxidative stress-induced apoptosis is associated with alterations in mitochondrial caspase activity and Bcl-2-dependent alterations in mitochondrial pH (pHm", BRAIN RES BULL., (20040215), vol. 62, no. 6, pages 497 - 504
    - TANIYAMA Y, GRIENDLING KK., "Reactive oxygen species in the vasculature: molecular and cellular mechanisms", HYPERTENSION, (20031027), vol. 42, no. 6, pages 1075 - 81
    - HIGUCHI Y., "Chromosomal DNA fragmentation in apoptosis and necrosis induced by oxidative stress", BIOCHEM PHARMACOL., (20031015), vol. 66, no. 8, pages 1527 - 35
    - PUNJ V, CHAKRABARTY AM., "Redox proteins in mammalian cell death: an evolutionarily conserved function in mitochondria and prokaryotes", CELL MICROBIOL., (200304), vol. 5, no. 4, pages 225 - 31
    - UEDA S, MASUTANI H, NAKAMURA H, TANAKA T, UENO M, YODOI J., "Redox control of cell death", ANTIOXID REDOX SIGNAL., (200206), vol. 4, no. 3, pages 405 - 14
    - RAHMAN I., "Oxidative stress and gene transcription in asthma and chronic obstructive pulmonary disease: antioxidant therapeutic targets", CURR DRUG TARGETS INFLAMM ALLERGY, (200209), vol. 1, no. 3, doi:doi:10.2174/1568010023344607, pages 291 - 315, XP008038264

DOI:   http://dx.doi.org/10.2174/1568010023344607
    - RENARD P, RAES M., "The proinflammatory transcription factor NFkappaB: a potential target for novel therapeutical strategies", CELL BIOL TOXICOL., (1999), vol. 15, no. 6, pages 341 - 4
    - LENTSCH AB, WARD PA., "The NFkappaBb/IkappaB system in acute inflammation", ARCH IMMUNOL THER EXP, (2000), vol. 48, no. 2, pages 59 - 63
    - ANDELA VB, GORDON AH, ZOTALIS G, ROSIER RN, GOATER JJ, LEWIS GD, SCHWARZ EM, PUZAS JE, O'KEEFE RJ., "NFkappaB: a pivotal transcription factor in prostate cancer metastasis to bone", CLIN ORTHOP., (200310), vol. 415, pages 75 - 85
    - FLEENOR DL, PANG IH, CLARK AF., "Involvement of AP-1 in interleukin-lalpha-stimulated MMP-3 expression in human trabecular meshwork cells", INVEST OPHTHALMOL VIS SCI., (200308), vol. 44, no. 8, pages 3494 - 501
    - RUHUL AMIN AR, SENGA T, OO ML, THANT AA, HAMAGUCHI M., "Secretion of matrix metalloproteinase-9 by the proinflammatory cytokine, IL-lbeta: a role for the dual signalling pathways", AKT AND ERK. GENES CELLS, (200306), vol. 8, no. 6, pages 515 - 23
    - YASUNORI KASAHARA, RUBIN M. TUDER, CARLYNE D. COOL, DAVID A. LYNCH, SONIA C. FLORES, NORBERT F. VOELKEL, "Endothelial Cell Death and Decreased Expression of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor 2 in Emphysema", AM J RESPIR CRIT CARE MED, (2001), vol. 163, pages 737 - 744
    - YASUNORI KASAHARA, RUBIN M. TUDER, LAIMUTE TARASEVICIENE-STEWART, TIMOTHY D. LE CRAS, STEVEN ABMAN, PETER K. HIRTH, JOHANNES WALTE, "Inhibition of VEGF receptors causes lung cell apoptosis and emphysema", J. CLIN. INVEST., (2000), vol. 106, pages 1311 - 1319, XP002593900
    - VOELKEL NF, COOL CD., "Pulmonary vascular involvement in chronic obstructive pulmonary disease", EUR RESPIR J, (200311), vol. 46, pages 28S - 32S
    - HAMDI, KENNEY, "Age-related Macular degeneration - a new viewpoint", FRONTIERS IN BIOSCIENCE, (200305), pages E305 - 314
    - MILTON, AM J OPHTHALMOL, (1979), vol. 88, page 269
    - MITCHELL ET AL., OPHTHALMOLOGY, (1995), vol. 102, pages 1450 - 1460
    - SMITH ET AL., OPHTHALMOLOGY, (2001), vol. 108, pages 697 - 704
    - KLEIN ET AL., OPHTHALMOLOGY, (1992), vol. 99, pages 933 - 943
    - American Journal of Surgery, ELSEVIER, (20040501), vol. 187
    - AM J PHYSIOL, (2003), vol. 285
    - HYPERT RES, (2002), vol. 25, page 893
    - SAMBUCETI ET AL., CIRCULATION, (2001), vol. 104, page 1129
    - TIWARI, VIKRANT, "Review Article- Sepsis and the Kidney", JOURNAL OF INDIAN ACADEMY OF CLINICAL MEDICINE, vol. 5, no. 1
    - Goodman and Gilman's The Pharmacological Basis of Therapeutics, MACMILLAN PUBLISHING CO., INC., (1980), pages 1169 - 71
    - ZHANG ET AL., NEUROSCIENCE, (2003), vol. 120, pages 191 - 205
    - WANG ET AL., J. NEUROSCIENCE, vol. 23, no. 24, pages 8596 - 8607
    - TZIPORA SHOSHANI ET AL., "Identification of a Novel Hypoxia-Inducible Factor I-Responsive Gene, RTP801, Involved in Apoptosis", MOLECULAR AND CELLULAR BIOLOGY, (200204), doi:doi:10.1128/MCB.22.7.2283-2293.2002, pages 2283 - 2293, XP002267737

DOI:   http://dx.doi.org/10.1128/MCB.22.7.2283-2293.2002
    - ANAT BRAFINAN ET AL., "Inhibition of Oxygen-Induced Retinopathy in RTP801-Deficient Mice", INVEST OPHTHALMOL VIS SCI., (200410), vol. 45, no. 10, doi:doi:10.1167/IOVS.04-0052, pages 3796 - 805, XP002633194

DOI:   http://dx.doi.org/10.1167/IOVS.04-0052
    - W. ELLISEN ET AL., "REDDl, a Developmentally Regulated Transcriptional Target ofp63 and p53, Links p63 to Regulation of Reactive Oxygen Species", MOLECULAR CELL, (200211), vol. 10, pages 995 - 1005
    - RICHARD DR, BERRA E, POUYSSEGUR J., "Non-hypoxic pathway mediates the induction of hypoxia-inducible factor 1 alpha in vascular smooth muscle cells", J BIOL. CHEM., vol. 275, no. 35, pages 26765 - 71
    - RANGASAMI T ET AL., "Genetic ablation ofNrj2 enhances susceptibility to cigarette smoke-induced emphysema in mice", JOURNAL OF CLINICAL INVESTIGATION
    - SHOSHANI ET AL., MOL CELL BIOL, (2002), vol. 22, pages 2283 - 93
    - ELLISEN ET AL., MOL CELL, vol. 10, pages 995 - 1005
    - HERSKOWITZ I., "Functional inactivation of genes by dominant negative mutations", NATURE, (19870917), vol. 329, no. 6136, doi:doi:10.1038/329219a0, pages 219 - 22, XP002924461

DOI:   http://dx.doi.org/10.1038/329219a0
    - RONINSON IB ET AL., "Genetic suppressor elements: new tools for molecular oncology--thirteenth Cornelius P. Rhoads Memorial Award Lecture", CANCER RES., (19950915), vol. 55, no. 18, page 4023
    - BIBL HAEMATOL., (1965), vol. 23, pages 1165 - 74
    - APPL MICROBIOL., (196707), vol. 15, no. 4, pages 851 - 6
    - CAN J BIOCHEM., (196805), vol. 46, no. 5, pages 441 - 4
    - BIOCHEMISTRY, (196807), vol. 7, no. 7, pages 2574 - 80
    - ARCH BIOCHEM BIOPHYS., (19680910), vol. 126, no. 3, pages 746 - 72
    - BIOCHEM BIOPHYS RES COMMUN., (19700220), vol. 38, no. 4, pages 825 - 30
    - VEGA ET AL., Gene Targeting, CRC PRESS
    - PADLAN, MOLECULAR IMMUNOLOGY, (1991), vol. 28, no. 4, 5, pages 489 - 498
    - STUDNICKA ET AL., PROTEIN ENGINEERING, (1994), vol. 7, no. 6, pages 805 - 814
    - ROGUSKA ET AL., PNAS, (1994), vol. 91, pages 969 - 973
    - FERRARA N., ENDOCR REV., (200408), vol. 25, no. 4, pages 581 - 611
    - TRAXLER P, CANCER RES., (20040715), vol. 64, no. 14, pages 4931 - 41
    - STADLER WM ET AL., CLIN CANCER RES., (20040515), vol. 10, no. 10, pages 3365 - 70
    - FIRE ET AL., NATURE, (1998), vol. 391, page 806
    - ELBASHIR ET AL., GENES DEV., (2001), vol. 15, page 188
    - BERNSTEIN E., DENLI AM., HANNON GJ, "The rest is silence", RNA, (200111), vol. 7, no. 11, pages 1509 - 21, XP009010244
    - NISHIKURA K., "A short primer on RNAi: RNA-directed RNA polymerase acts as a key catalyst", CELL, (20011116), vol. 107, no. 4, doi:doi:10.1016/S0092-8674(01)00581-5, pages 415 - 8, XP002959440

DOI:   http://dx.doi.org/10.1016/S0092-8674(01)00581-5
    - NATURE REVIEWS, (2002), vol. 3, pages 737 - 47
    - NATURE, (2002), vol. 418, pages 244 - 51
    - NATURE, (2001), vol. 409, pages 363 - 6
    - NATURE, (2003), vol. 425, pages 415 - 9
    - CURR OPIN MOL THER., (200306), vol. 5, no. 3, pages 217 - 24
    - PEI, TUSCHL, "On the Art of Identifying Effective and Specific siRNAs", NATURE METHODS, (200609), vol. 3, no. 9, doi:doi:10.1038/nmeth911, XP055027555

DOI:   http://dx.doi.org/10.1038/nmeth911
    - CHALK AM, WAHLESTEDT C, SONNHAMMER EL., "Improved and automated prediction of effective siRNA", BIOCHEM. BIOPHYS. RES. COMMUN., (20040618), vol. 319, no. 1, doi:doi:10.1016/j.bbrc.2004.04.181, pages 264 - 74, XP004509878

DOI:   http://dx.doi.org/10.1016/j.bbrc.2004.04.181
    - SIOUD M, LEIRDAL M., "Potential design rules and enzymatic synthesis of siRNAs", METHODS MOL BIOL., (2004), vol. 252, pages 457 - 69, XP001181161
    - LEVENKOVA N, GU Q, RUX JJ., "Gene specific siRNA selector", BIOINFORMATICS, (20040212), vol. 20, no. 3, pages 430 - 2, XP002311428
    - UI-TEI K, NAITO Y, TAKAHASHI F, HARAGUCHI T, OHKI-HAMAZAKI H, JUNI A, UEDA R, SAIGO K., "Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference", NUCLEIC ACIDS RES., (20040209), vol. 32, no. 3, doi:doi:10.1093/nar/gkh247, pages 936 - 48, XP002329955

DOI:   http://dx.doi.org/10.1093/nar/gkh247
    - LIU Y, BRAASCH DA, NULF CJ, COREY DR., "Efficient and isoform- selective inhibition of cellular gene expression by peptide nucleic acids", BIOCHEMISTRY, (20040224), vol. 43, no. 7, doi:doi:10.1021/bi0358519, pages 1921 - 7, XP055040311

DOI:   http://dx.doi.org/10.1021/bi0358519
    - CHIU YL, RANA TM., "siRNA function in RNAi: a chemical modification analysis", RNA, (200309), vol. 9, no. 9, doi:doi:10.1261/rna.5103703, pages 1034 - 48, XP008158876

DOI:   http://dx.doi.org/10.1261/rna.5103703
    - PADDISON ET AL., PNAS, (2002), vol. 99, pages 1443 - 1448
    - PADDISON ET AL., GENES & DEV, (2002), vol. 16, pages 948 - 958
    - SUI ET AL., PNAS, (2002), vol. 8, pages 5515 - 5520
    - BRUMMELKAMP ET AL., SCIENCE, (2002), vol. 296, pages 550 - 553
    - SHEN ET AL., FEBS LETTERS, (2003), vol. 539, pages 111 - 114
    - XIA ET AL., NATURE BIOTECHNOLOGY, (2002), vol. 20, pages 1006 - 1010
    - REICH ET AL., MOLECULAR VISION, (2003), vol. 9, pages 210 - 216
    - SORENSEN ET AL., J.MOL.BIOL., (2003), vol. 327, pages 761 - 766
    - LEWIS ET AL., NATURE GENETICS, (2002), vol. 32, pages 107 - 108
    - SIMEONI ET AL., NUCLEIC ACIDS RESEARCH, (2003), vol. 31, no. 11, pages 2717 - 2724
    - TOLENTINO ET AL., RETINA, (200402), vol. 24, no. 1, pages 132 - 138
    - STEMBERGER, M., SCHMIEDEKNECHT, A., KRETSCHMER, A., GEBHARDT, F., LEENDERS, F., CZAUDEMA, F., VON CARLOWITZ, I., ENGLE, M., GIESE,, ANTISENSE NUCLEIC ACID DRUG DEV, (2002), vol. 12, pages 131 - 43
    - ALI, I. U., JOURNAL OF THE NATIONAL CANCER INSTITUTE, (20000607), vol. 92, no. 11, pages 861 - 863
    - BEAUCAGE S.L., IYER R.P., TETRAHEDRON, (1992), vol. 48, pages 2223 - 2311
    - BEAUCAGE S.L., IYER R.P., TETRAHEDRON, (1993), vol. 49, pages 6123 - 6194
    - CARUTHERS M.H., METHODS ENZYMOL., (1987), vol. 154, pages 287 - 313
    - ECKSTEIN F., ANNU. REV. BIOCHEM., (1985), vol. 54, pages 367 - 402
    - CALABRETTA ET AL., "Antisense strategies in the treatment of leukemias", SEMIN ONCOL., (1996), vol. 23, no. 1, pages 78 - 87, XP000983404
    - WRIGHT, ANAZODO, "Antisense Molecules and Their Potential For The Treatment Of Cancer and AIDS", CANCER J., (1995), vol. 8, pages 185 - 189, XP002089434
    - CROOKE, "Progress in antisense therapeutics", HEMATOL. PATHOL., (1995), vol. 2, page 59
    - UHLMANN, PEYMAN, "Antisense Oligonucleotides: A New Therapeutic Principle", CHEM REV, (1990), vol. 90, no. 4, doi:doi:10.1021/cr00102a001, pages 543 - 584, XP000141412

DOI:   http://dx.doi.org/10.1021/cr00102a001
    - WAGNER, "Gene inhibition using antisense oligodeoxynucleotides", NATURE, (1994), vol. 372, page 333
    - HANANIA ET AL., "Recent advances in the application of gene therapy to human disease", AM. J. MED., (1995), vol. 99, page 537
    - SCANLON ET AL., "Oligonucleotides-mediated modulation of mammalian gene expression", FASEB J., (1995), vol. 9, page 1288
    - GEWIRTZ, "Oligodeoxynucleotide-based therapeutics for human leukemias", STEM CELLS DAYT., (1993), vol. 11, page 96
    - LEFEBVRE-DHELLENCOURT ET AL., "Immunomodulation by cytokine antisense oligonucleotides", EUR. CYTOKINE NETW., (1995), vol. 6, page 7, XP000570645
    - AGRAWAL, "Antisense oligonucleotides: towards clinical trials", TIBTECH, (1996), vol. 14, doi:doi:10.1016/0167-7799(96)10053-6, page 376, XP004035728

DOI:   http://dx.doi.org/10.1016/0167-7799(96)10053-6
    - CALABRETTA ET AL., "Antisense strategies in the treatment of leukemias", SEMIN. ONCOL., (1996), vol. 23, page 78, XP000983404
    - GALILEO ET AL., J. CELL. BIOL., (1991), vol. 112, page 1285
    - ROSOLEN ET AL., CANCER RES., (1990), vol. 50, page 6316
    - WHITESELL ET AL., "Episome-generated N-myc antisense RNA restricts the differentiation potential of primitive neuroectodermal cell lines", MOL. CELL. BIOL., (1991), vol. 11, page 1360
    - MORRISON, "Suppression of basic fibroblast growth factor expression by antisense oligonucleotides inhibits the growth of transformed human astrocytes", J. BIOL. CHEM., (1991), vol. 266, page 728
    - AKHTER ET AL., "Interactions of antisense DNA oligonucleotide analogs with phospholipid membranes (liposomes", NUC. RES., (1991), vol. 19, pages 5551 - 5559
    - LOKE ET AL., "Characterization of oligonucleotide transport into living cells", PNAS USA, (1989), vol. 86, page 3474
    - YAKUBOV ET AL., PNAS USA, (1989), vol. 86, page 6454
    - SARVER ET AL., GENE REGULATION AND AIDS, (1990), pages 305 - 325
    - WILBUR, LIPMAN, PROC. NATL. ACAD. SCI. USA, (1983), vol. 80, page 726
    - ALTSCHUL ET AL., NUCL. ACIDS RES., vol. 25, pages 3389 - 3402
    - SMITH ET AL., ADV. APPL. MATH., (1981), vol. 2, pages 482 - 489
    - SMITH ET AL., NUCL. ACIDS RES., (1983), vol. 11, pages 2205 - 2220
    - DEVEREUX ET AL., NUCL. ACIDS RES., (1984), vol. 12, pages 387 - 395
    - FENG ET AL., J. MOLEC. EVOL., (1987), vol. 25, pages 351 - 360
    - HIGGINS ET AL., CABIOS, (1989), vol. 5, pages 151 - 153
    - THOMPSON ET AL., NUCL. ACIDS RES., (1994), vol. 22, pages 4673 - 4680
    - Organic syntheses, J. WILEY, (1941), vol. 1- 79
    - Comprehensive Medicinal Chemistry, PERGAMON PRESS
    - CZAUDEMA, F., FECHTNER, M., AYGUN, H., ARNOLD, W., KLIPPEL, A., GIESE, K., KAUFMANN, J., NUCLEIC ACIDS RES, (2003), vol. 31, pages 670 - 82
    - METHODS FIND EXP CLIN PHARMACOL., (199705), vol. 19, no. 4, pages 231 - 9
    - KLIPPEL, A., ESCOBEDO, M.A., WACHOWICZ, M.S., APELL, G., BROWN, T.W., GIEDLIN, M.A., KAVANAUGH, W.M., WILLIAMS, L.T., MOL CELL BIOL, (1998), vol. 18, pages 5699 - 711
    - KLIPPEL, A., REINHARD, C., KAVANAUGH, W.M., APELL, G., ESCOBEDO, M.A., WILLIAMS, L.T., MOL CELL BIOL, (1996), vol. 16, pages 4117 - 27
    - SAKURAI ET AL., IOVS, (2003), vol. 44, pages 3578 - 85
    - SAKURAI ET AL., IOVS, (2003), vol. 44, pages 2743 - 2749
    - CHADER, VISION RESEARCH, (2002), vol. 42, pages 393 - 399
    - AMBATI ET AL., NATURE MEDICINE, (2003), vol. 9, no. 11, pages 1390 - 1397
    - TOLENTINO ET AL., RETINA, (2004), vol. 24, pages 132 - 138
    - RANGASAMY T, CHO CY, THIMMULAPPA, RK, ZHEN L, SRISUMA SS, KENSLER TW, YAMAMOTO M, PETRACHE I, TUDER RM, "Genetic ablation ofNrj2 enhances susceptibility to cigarette smoke-iduced emphysema in mice. Submitted to Journal of Clinincal Investigation", BISWAL S.
    - YASUNORI KASAHARA, RUBIN M. TUDER, CARLYNE D. COOL, DAVID A. LYNCH, SONIA C. FLORES, NORBERT F. VOELKEL., "Endothelial Cell Death and Decreased Expression of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor 2 in Emphysema", AM J RESPIR CRIT CARE MED, (2001), vol. 163, pages 737 - 744
    - LONGA ET AL., STROKE, (1989), vol. 30, page 84
    - DOGAN ET AL., J. NEUROCHEM., (1999), vol. 72, page 765
    - TAMURA A. ET AL., J CEREB BLOOD FLOW METAB., (1981), vol. 1, pages 53 - 60
    - MIYAJI T, HU X, YUEN PS, MURAMATSU Y, IYER S, HEWITT SM, STAR RA, "Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice", KIDNEY INT., (200311), vol. 64, no. 5, doi:doi:10.1046/j.1523-1755.2003.00268.x, pages 1620 - 31, XP002405486

DOI:   http://dx.doi.org/10.1046/j.1523-1755.2003.00268.x
    - KELLY KJ, PLOTKIN Z, VULGAMOTT SL, DAGHER PC, "P53 mediates the apoptotic response to GTP depletion after renal ischemia- reperfusion: protective role of a p53 inhibitor", J AM SOC NEPHROL., (200301), vol. 14, no. 1, doi:doi:10.1097/01.ASN.0000040596.23073.01, pages 128 - 38, XP002632231

DOI:   http://dx.doi.org/10.1097/01.ASN.0000040596.23073.01
    - USMAN ET AL., J. AM. CHEM. SOC., (1987), vol. 109, page 7845
    - SCARINGE ET AL., NUCLEIC ACIDS RES., (1990), vol. 18, page 5433
    - WINCOTT ET AL., NUCLEIC ACIDS RES., (1995), vol. 23, pages 2677 - 2684
    - WINCOTT ET AL., METHODS MOL. BIO., (1997), vol. 74, page 59
    - MOORE ET AL., SCIENCE, (1992), vol. 256, page 9923
    - SHABAROVA ET AL., NUCLEIC ACIDS RESEARCH, (1991), vol. 19, page 4247
    - BELLON ET AL., NUCLEOSIDES & NUCLEOTIDES, (1997), vol. 16, page 951
    - BELLON ET AL., BIOCONJUGATE CHEM., (1997), vol. 8, page 204
    - WEISS ET AL., HUMAN GENE THERAPY, (1999), vol. 10, pages 2287 - 2293
    - DENSMORE ET AL., MOLECULAR THERAPY, (1999), vol. 1, pages 180 - 188
    - GAUTAM ET AL., MOLECULAR THERAPY, (2001), vol. 3, pages 551 - 556
    - SHAHIWALA, MISRA, AAPS PHARMSCITECH, (2004), vol. 5
    - TANAKA ET AL., HEAR RES., (200303), vol. 177, no. 1-2, pages 21 - 31
    - SONG ET AL., "Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors", NAT BIOTECHNOL., (200506), vol. 23, no. 6, doi:doi:10.1038/nbt1101, pages 709 - 17, XP002390626

DOI:   http://dx.doi.org/10.1038/nbt1101
    - DING ET AL., HEARING RESEARCH, (2002), vol. 164, pages 115 - 126
    - WANG ET AL., THE JOURNAL OFNEUROSCIENCE, vol. 23, no. 24, pages 8596 - 8607
    - WANG ET AL., THE JOURNAL OF NEUROSCIENCE, vol. 23, no. 24, pages 8596 - 8607
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.